Ironwood Pham (IRWD) and Forest Labs (FRX) Announces Presentation Plans for Linaclotide Results from Phase 2B and Phase 3 Trials
Go back to Ironwood Pham (IRWD) and Forest Labs (FRX) Announces Presentation Plans for Linaclotide Results from Phase 2B and Phase 3 Trials| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.33 -0.03 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $16.89 | |||
| Open | $4.35 | 52 Week Low | $7.35 | |||
| Day High | $4.40 | P/E | N/A | |||
| Day Low | $4.29 | EPS | $-2.35 | |||
| Volume | 314,676 | |||||
